Genetic Code-Locking Gives Recoded Organisms Stable Virus Resistance, Eliminating a Key Biomanufacturing Risk

Published in Biochemistry in 2025, this paper demonstrates that the virus resistance conferred by genome recoding is stable across many generations, addressing a key question for industrial deployment of recoded production organisms.

Bacteriophage contamination is one of the most significant risks in E. coli fermentation. A single phage outbreak can destroy an entire production batch, and conventional defences (cleanroom protocols, filtration, antibiotic selection) add cost and complexity without providing complete protection. Earlier work from the Chin group showed that Syn61-derived strains are resistant to phage infection because the viruses depend on codons that have been removed from the host genome. What remained to be demonstrated was whether this resistance holds up over the extended timescales relevant to industrial manufacturing.

This paper provides that evidence. The researchers show that genetic code-locking, the mechanism by which refactored codons create a translational barrier to viral replication, confers resistance that persists stably through prolonged growth and serial passage. The recoded organism does not revert to phage susceptibility over time, because the resistance is structural: it is encoded across the entire genome rather than relying on a single gene or plasmid that could be lost or mutated.

For biomanufacturing, stability matters as much as the initial resistance. Production campaigns for peptide therapeutics involve many generations of cell growth from master cell bank through working cell bank to production scale. A resistance mechanism that degrades over these generations would be unreliable in practice. This work demonstrates that code-locking does not degrade, providing a level of phage protection that is inherent to the organism rather than dependent on process controls.

This directly supports the risk profile of Constructive Bio's BioForge manufacturing platform, where Syn61-derived production strains carry this built-in phage resistance as a standard feature of the recoded chassis.